Metformin, a weightreducing drug in the obese pediatric population?

Phase 4

Withdrawn

• Conditions: Obesitas (obesity); Obesity; overweight

• Registration Number: NL-OMON30455
• Lead Sponsor: Máxima Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 40

Inclusion Criteria

Obesity
Age 10-18 years

Exclusion Criteria

Diabetes mellitus

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Bodyweight</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Effect on the cardiovascular risk profile<br /><br>Effect on the quality of life </p><br>